Diode laser treatment for retinopathy of prematurity was successful in 81% of 21 eyes with 'threshold' (zone 2, stage 3+) disease. This compares favourably with cryotherapy and argon laser photocoagulation. The retinal outcome and technique are discussed. (BrJ Ophthalmol 1993; 77: 559-562) 
Retinopathy of prematurity (ROP) is one of the leading causes of blindness among children in the developed world. i 2 It is the commonest cause of blindness arising in the perinatal period and leads to 11% of childhood blindness in the Republic of Ireland. 3 The multicentre North American cryotherapy study (Cryo-ROP) demonstrated a significant decrease in the incidence of blinding disease by treatment of 'threshold' disease." 6 Photocoagulation for ROP has been described in the past.7-'2 Recent studies suggest that argon laser'3 and diode laser'4 photocoagulation, with indirect ophthalmoscope delivery systems, is at least as effective as cryotherapy in preventing adverse outcome in 'threshold' ROP. Laser photocoagulation of the retina without the use of a contact lens and slit-lamp has long been possible. With advances in indirect ophthalmoscope delivery systems and the advent of the highly portable diode laser, it is now possible to deliver this treatment in the neonatal intensive care unit.
The outcome and clinical course of 12 consecutive premature infants (21 eyes) treated with diode laser retinal photocoagulation for threshold ROP or more severe disease is described. disease). Examinations are carried out through dilated pupils with the use of a speculum and indentation. Treatment In seven children ROP was present at the first screening examination. In the other five children in whom the ROP was not present at first sighting the mean postconceptual age of onset was 34-6 weeks (range 34-36). In 10 cases the progression to threshold disease was observed after the first examination during routine follow up and the mean postconceptual age of the development ofthreshold disease was 35 7 weeks (range 33-40). In two cases (8 and 9) it was at threshold level at the first examination.
Seventeen eyes (81%) of the 21 Table 1 for details of laser treatment parameters in individual cases.) Regression was noted, on average, 5 days after application of adequate laser therapy (range [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] .
The mean follow up in these cases is 13 The clinical findings in three cases in this series raise the question, long discussed, of the optimum siting of treatment on the retina.9 18 22 23 These observations include the short lived success with unconventional treatment of stage 4 disease mentioned above in case 8 (where laser was applied behind the mesenchymal shunt), the more lasting success with the same technique in the left eye in case 5, and the lack of success with more conventional treatment of the same level of disease in the fellow eye in case 5 where the treatment was applied only anterior to the ridge. Should the ridge be treated, or even the anterior shunt bearing vascularised retina, on a routine basis? It has been our experience that where laser treatment was inadvertently applied directly to the ridge it caused vitreous and retinal haemorrhage from the abnormal, friable new vessels.
Some cases reported here raise further questions about the techniques currently in use for treatment of ROP. Perhaps a quarter of the cases of threshold disease go on to an unfavourable outcome according to the Cryo-ROP study,6 and two eyes in this series had unfavourable outcomes from stage 3 disease at the time of first treatment (case 9 left eye and case 11 right eye). The criteria for threshold disease were established on the basis of clinical experience in the main and were not the subject of a controlled study. Recent reports are encouraging regarding the treatment of early disease in some circumstances.2425 It will also be important to assess critically the visual function of those children with macular traction long term, since clinical experience would suggest that a proportion of these children have useful visual function that distinguishes them from those more severely affected and raises a question over the appropriateness of their inclusion in the formally defined 'unfavourable outcome' category.4
These categories were defined on the basis of structural outcome (that is, 'unfavourable' designates macular retinal detachment or worse) irrespective of function. It is now appropriate that categorisation of outcome should include functional criteria in the light of a recent paper on this topic. 6 Individual outcome in this series raises a number of questions regarding the screening of at risk neonates. It is the policy of this unit to screen all neonates born at 30 weeks' gestation or less and/or a birth weight of 1500 grams or less. The first examination takes place at 6 weeks' postnatal age. The 28 The practice in this unit is to use general anaesthesia in all cases treated with cryotherapy since we have concluded that this gives better pain relief, allows for better control of these complications, and makes the application of cryotherapy easier." Further advantages of laser therapy may be summarised as the rapid response to adequate treatment, or conversely, rapid diagnosis of inadequate treatment, the ease of repeat treatment, application in the neonatal unit (with the diode laser) facilitating rapid treatment after diagnosis of threshold disease, avoidance of lesions to the eye wall and external eye that are part of transconjunctival cryotherapy, and cryotherapy applied direct to the sclera and probable minimisation of inflammation and vitreous traction.
The disadvantages are confined to inadvertent burns to structures other than avascular retina including the fovea, the difficulty of use with hazy media and small pupils, and the lack oflong term experience with this modality. Furthermore, the authors have seen apnoea occur, on rare occasions, following diode laser photocoagulation, and there is also the comparative painfulness of diode laser treatment compared with argon or krypton.'5 The extra capital and maintenance costs of a diode laser system are not inconsiderable.
This series confirms that diode laser photocoagulation is an effective treatment for threshold ROP and further controlled trials are needed to refine it.
